Loading clinical trials...
Loading clinical trials...
The objective of this study is to test the scale structure, reliability, validity and responsiveness to change of the QLQ-CML24 in conjuction with the QLQ-C30 for patients diagnosed with CML, and to i...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
NCT06514534 · Chronic Myeloid Leukemia (CML)
NCT05143840 · Chronic Myeloid Leukemia, Chronic Phase, Adult CML, and more
NCT06994676 · High-risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia (CMML), and more
NCT06523556 · Atypical Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, and more
NCT06236724 · Chronic Myeloid Leukemia
Winship Cancer Institute of Emory University
Emory, Georgia
Innsbruck Medical University
Innsbruck
Complexo Hospital de Clinicas da Universidade Federal do Parana
Paranã
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions